14282-65-6 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
2-Thiophenecarboxylic acid, 4-(hydroxymethyl)is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure allows for the creation of complex molecules with potential therapeutic and pesticidal properties.
Used in Organic Synthesis:
As a building block, 2-Thiophenecarboxylic acid, 4-(hydroxymethyl)is utilized in the preparation of a wide range of organic compounds, contributing to the development of new chemical entities with diverse applications.
Used in Material Science:
2-Thiophenecarboxylic acid, 4-(hydroxymethyl)-'s potential applications in material science include the development of new materials and catalysts, where its unique structure and functional groups can enhance the properties and performance of these materials.
Used in Chemical Research and Analysis:
2-Thiophenecarboxylic acid, 4-(hydroxymethyl)also serves as a reagent in chemical research and analysis, aiding in the investigation of various chemical reactions and processes.
Check Digit Verification of cas no
The CAS Registry Mumber 14282-65-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,2,8 and 2 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 14282-65:
(7*1)+(6*4)+(5*2)+(4*8)+(3*2)+(2*6)+(1*5)=96
96 % 10 = 6
So 14282-65-6 is a valid CAS Registry Number.
14282-65-6Relevant academic research and scientific papers
TRICYCLIC DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Page 75, (2010/02/10)
The present invention relates to tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. More precisely, the present invention relates to tricyclic derivatives as colchicine derivatives, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. Tricyclic derivatives of the present invention show very powerful cytotoxicity to cancer cell lines but were much less toxic than colchicine or taxol, confirmed through animal toxicity test. Tricyclic derivatives of the invention also decrease the volume and weight of a tumor and have a strong angiogenesis inhibiting activity in HUVEC cells. Thus, tricyclic derivatives of the present invention can effectively be used as an anticancer agent, anti-proliferation agent and an angiogenesis inhibitor.
